Rep Kelly K. Convirs-Fowler (HD-021)
Virginia Housesince 10 months
SEE LATEST
SPONSORED LEGISLATION
HB1472 - Water certificates or permits; compliance with water quality standards.
Debra D. Gardner, Nadarius E. Clark, Kelly K. Convirs-Fowler
Last updated 10 months ago
6 Co-Sponsors
Water certificates or permits; compliance with water quality standards. Requires the State Water Control Board to ensure all activities allowed under any water certificate or permit are in compliance with the water quality standards promulgated by the Board.
STATUS
Introduced
HB255 - Adult wellness screening; sickle cell disease or sickle cell trait.
Candi Mundon King, Bonita Grace Anthony, Alex Q. Askew
Last updated 8 months ago
17 Co-Sponsors
Adult wellness screening; sickle cell disease or sickle cell trait. Provides that every adult resident of the Commonwealth may be offered screening tests for sickle cell disease or the sickle cell trait and requires that the health care professional in charge of an adult's annual health examination provide education and appropriate counseling regarding the results of any such test that is performed. Adult wellness screening; sickle cell disease or sickle cell trait. Provides that every adult resident of the Commonwealth may be offered screening tests for sickle cell disease or the sickle cell trait and requires that the health care professional in charge of an adult's annual health examination provide education and appropriate counseling regarding the results of any such test that is performed.
STATUS
Passed
HB362 - Firearms; purchase, etc., following an assault and battery of a family or household member, etc.
Adele Y. McClure, Dan I. Helmer, Bonita Grace Anthony
Last updated 8 months ago
24 Co-Sponsors
Purchase, possession, or transportation of firearm; assault and battery of a family or household member or intimate partner; penalties. Adds to the existing definition of "family or household member" a person's intimate partner, defined in the bill as an individual who, within the previous 12 months, was in a romantic, dating, or sexual relationship with the person. The bill also provides that any person who knowingly and intentionally purchases, possesses, or transports any firearm following a misdemeanor conviction for an offense that occurred on or after July 1, 2024, for the offense of assault and battery against an intimate partner or an offense substantially similar under the laws of any other state or of the United States is guilty of a Class 1 misdemeanor.
STATUS
Vetoed
HB1415 - Historic structures; civil penalty for demolition.
Delores L. McQuinn, Kelly K. Convirs-Fowler, Nadarius E. Clark
Last updated 7 months ago
8 Co-Sponsors
Civil penalty for demolition of historic structures. Authorizes any locality to adopt an ordinance establishing a civil penalty for the razing, demolition, or moving of a building or structure that is located in a historic district or that has been designated by a governing body as a historic structure or landmark in violation of an ordinance that no such building or structure shall be razed, demolished, or moved without the approval of a review board. The bill provides that such civil penalty shall not exceed the market value of the property as determined by the assessed value of the property at the time of razing, demolition, or moving of the building or structure. Civil penalty for demolition of historic structures. Authorizes any locality to adopt an ordinance establishing a civil penalty for the razing, demolition, or moving of a building or structure that is located in a historic district or that has been designated by a governing body as a historic structure or landmark in violation of an ordinance that no such building or structure shall be razed, demolished, or moved without the approval of a review board. The bill provides that such civil penalty shall not exceed the market value of the property as determined by the assessed value of the property at the time of razing, demolition, or moving of the building or structure.
STATUS
Passed
HB238 - Health insurance; coverage for colorectal cancer screening.
Delores L. McQuinn, Bonita Grace Anthony, Elizabeth B. Bennett-Parker
Last updated 8 months ago
24 Co-Sponsors
Health insurance; coverage for colorectal cancer screening. Requires health insurers to provide coverage for examinations and laboratory tests related to colorectal cancer screening in accordance with the most recently published recommendations established by the U.S. Preventive Services Task Force for colorectal cancer screening for which a rating of A or B is in effect with respect to the individual involved. The bill requires such coverage to include coverage of a follow-up colonoscopy after a positive noninvasive stool-based screening test or direct visualization screening test. The bill prohibits such coverage from being subject to any deductible, coinsurance, or any other cost-sharing requirements for services received from participating providers. The provisions of the bill apply to individual or group accident and sickness insurance policies, individual or group accident and sickness subscription contracts, or health care plans delivered, issued for delivery, or renewed in the Commonwealth on and after January 1, 2025. Health insurance; coverage for colorectal cancer screening. Requires health insurers to provide coverage for examinations and laboratory tests related to colorectal cancer screening in accordance with the most recently published recommendations established by the U.S. Preventive Services Task Force for colorectal cancer screening for which a rating of A or B is in effect with respect to the individual involved. The bill requires such coverage to include coverage of a follow-up colonoscopy after a positive noninvasive stool-based screening test or direct visualization screening test. The bill prohibits such coverage from being subject to any deductible, coinsurance, or any other cost-sharing requirements for services received from participating providers. The provisions of the bill apply to individual or group accident and sickness insurance policies, individual or group accident and sickness subscription contracts, or health care plans delivered, issued for delivery, or renewed in the Commonwealth on and after January 1, 2025.
STATUS
Passed
HB368 - Uniform Statewide Building Code; Board of HCD to convene advisory group to evaluate.
Adele Y. McClure, Betsy B. Carr, Kelly K. Convirs-Fowler
Last updated 8 months ago
8 Co-Sponsors
Board of Housing and Community Development; stakeholder advisory group; report. Directs the Board of Housing and Community Development (the Board) to convene a stakeholder advisory group including fire code officials to evaluate and recommend revisions to the Uniform Statewide Building Code to permit Group R-2 occupancies to be served by a single exit, provided that the building has not more than six stories above grade plane. The bill requires the stakeholder advisory group to submit its findings and recommendations to the Board and to the Chairmen of the House Committee on General Laws and the Senate Committee on General Laws and Technology no later than December 1, 2024.
STATUS
Passed
HJR14 - Wolf Creek Cherokee Tribe of Virginia; General Assembly to extend state recognition.
Delores L. McQuinn, Nadarius E. Clark, Joshua G. Cole
Last updated 11 months ago
17 Co-Sponsors
Recognition of the Wolf Creek Cherokee Tribe of Virginia. Extends state recognition to the Wolf Creek Cherokee Tribe of Virginia within the Commonwealth.
STATUS
Introduced
HB134 - Opioids; DOE to develop education materials concerning risks.
Kelly K. Convirs-Fowler, Carrie Emerson Coyner, Marcia S. Price
Last updated 8 months ago
4 Co-Sponsors
Department of Education; development of education materials relating to risks of opioids. Requires the Department of Education, in consultation with such stakeholders and experts as it deems necessary or appropriate, to develop and submit to the Chairs of the House Committee on Education and the Senate Committee on Education and Health by November 1, 2024, (i) age-appropriate and evidence-based education materials concerning the risks to health and safety that are posed by opioids and (ii) guidelines for school boards for incorporating such education materials into instructional programs for students enrolled in the local school division. Department of Education; development of education materials relating to risks of opioids. Requires the Department of Education, in consultation with such stakeholders and experts as it deems necessary or appropriate, to develop and submit to the Chairs of the House Committee on Education and the Senate Committee on Education and Health by November 1, 2024, (i) age-appropriate and evidence-based education materials concerning the risks to health and safety that are posed by opioids and (ii) guidelines for school boards for incorporating such education materials into instructional programs for students enrolled in the local school division.
STATUS
Passed
HB161 - Individuals experiencing or reporting overdoses while incarcerated; disciplinary procedures.
Holly M. Seibold, Nadarius E. Clark, Laura Jane Cohen
Last updated 8 months ago
11 Co-Sponsors
Arrest, prosecution, and disciplinary or administrative procedures and penalties for individuals experiencing or reporting overdoses while incarcerated. Provides that no individual incarcerated in a local, regional, or state correctional facility shall be subject to arrest or prosecution for or disciplinary or administrative procedures or penalties related to the unlawful purchase, possession, or consumption of alcohol; possession of a controlled substance; possession of marijuana; procurement, sale, secretion, or possession of any chemical compound not lawfully received; intoxication in public; or possession of controlled paraphernalia if such individual seeks or obtains emergency medical attention for himself or another individual experiencing an overdose or is experiencing an overdose and another individual seeks or obtains emergency medical attention for him. The bill also provides that no correctional officer, deputy sheriff, or jail officer acting in good faith shall be found liable for false arrest if it is later determined that the person arrested was immune from prosecution or disciplinary procedures or penalties. Arrest, prosecution, and disciplinary or administrative procedures and penalties for individuals experiencing or reporting overdoses while incarcerated. Provides that no individual incarcerated in a local, regional, or state correctional facility shall be subject to arrest or prosecution for or disciplinary or administrative procedures or penalties related to the unlawful purchase, possession, or consumption of alcohol; possession of a controlled substance; possession of marijuana; procurement, sale, secretion, or possession of any chemical compound not lawfully received; intoxication in public; or possession of controlled paraphernalia if such individual seeks or obtains emergency medical attention for himself or another individual experiencing an overdose or is experiencing an overdose and another individual seeks or obtains emergency medical attention for him. The bill also provides that no correctional officer, deputy sheriff, or jail officer acting in good faith shall be found liable for false arrest if it is later determined that the person arrested was immune from prosecution or disciplinary procedures or penalties.
STATUS
Vetoed
HB570 - Prescription Drug Affordability Board; established, drug cost affordability review, report.
Karrie K. Delaney, Nadarius E. Clark, Dan I. Helmer
Last updated 8 months ago
27 Co-Sponsors
Prescription Drug Affordability Board established; drug cost affordability review. Establishes the Prescription Drug Affordability Board for the purpose of protecting the citizens of the Commonwealth and other stakeholders within the health care system from the high costs of prescription drug products. The bill requires the Board to meet in open session at least four times annually, with certain exceptions and requirements enumerated in the bill. Members of the Board are required to disclose any conflicts of interest, as described in the bill. The bill also creates a stakeholder council for the purpose of assisting the Board in making decisions related to drug cost affordability. The bill tasks the Board with identifying prescription, generic, and other drugs, as defined in the bill, that are offered for sale in the Commonwealth and, at the Board's discretion, conducting an affordability review of any prescription drug product. The bill lists factors for the Board to consider that indicate an affordability challenge for the health care system in the Commonwealth or high out-of-pocket costs for patients. The bill also provides that any person aggrieved by a decision of the Board may request an appeal of the Board's decision and that the Attorney General has authority to enforce the provisions of the bill. The bill provides that the Board shall establish no more than 12 upper payment limit amounts annually between January 1, 2025, and January 1, 2028. Prescription Drug Affordability Board established; drug cost affordability review. Establishes the Prescription Drug Affordability Board for the purpose of protecting the citizens of the Commonwealth and other stakeholders within the health care system from the high costs of prescription drug products. The bill requires the Board to meet in open session at least four times annually, with certain exceptions and requirements enumerated in the bill. Members of the Board are required to disclose any conflicts of interest, as described in the bill. The bill also creates a stakeholder council for the purpose of assisting the Board in making decisions related to drug cost affordability. The bill tasks the Board with identifying prescription, generic, and other drugs, as defined in the bill, that are offered for sale in the Commonwealth and, at the Board's discretion, conducting an affordability review of any prescription drug product. The bill lists factors for the Board to consider that indicate an affordability challenge for the health care system in the Commonwealth or high out-of-pocket costs for patients. The bill also provides that any person aggrieved by a decision of the Board may request an appeal of the Board's decision and that the Attorney General has authority to enforce the provisions of the bill. The bill provides that the Board shall establish no more than 12 upper payment limit amounts annually between January 1, 2025, and January 1, 2028. The bill requires the Board to report its findings and recommendations to the General Assembly twice annually, beginning on July 1, 2025, and December 31, 2025. Provisions of the bill shall apply to state-sponsored and state-regulated health plans and health programs and obligate such policies to limit drug payment amounts and reimbursements to an upper payment limit amount set by the Board, if applicable, following an affordability review. The bill specifies that Medicare Part D plans shall not be bound by such decisions of the Board. The bill also requires the nonprofit organization contracted by the Department of Health to provide prescription drug price transparency to provide the Board access to certain data reported by manufacturers. The bill has a delayed effective date of January 1, 2025, and is identical to
STATUS
Vetoed
BIOGRAPHY
INCUMBENT
Representative from Virginia district HD-021
COMMITTEES
Virginia House
BIRTH
--
ABOUT
--
OFFICES HELD
Virginia House from Virginia
NEXT ELECTION
Kelly hasn't been asked any questions.
Be the first to ask a questionVerifications Required
You must be a verified voter to do that.
Error
You must be a resident or registered voter in this state.